LBI, (Ludwig Boltzmann Institute for Health Technology Assessment) Austria, has published a national report based on a EUnetHTA pilot rapid assessment of the herpes zoster vaccine, Zostavax®.
The first meeting of the HTA network of national authorities or bodies responsible for health technology assessment took place on October 16, 2013.
The EUnetHTA Conference "HTA 2.0 - Teaming up for Value" will take place October 30-31, 2014 in Rome, Italy. The programme and registration details will be available in the beginning of 2014.
The concept paper on Osteoarthritis "EunetHTA guideline on data requirements for the assessment of health technologies used for the treatment of osteoarthritis of the hip and knee" is available.
The EUnetHTA Executive Committee and Stakeholder Forum have agreed to introduce a co-chair function to strengthen engagement of the four stakeholder groups represented in the Stakeholder Forum, ie, providers, patients/consumers, payers and industry.